Mesenchymal stem cells (MSC) offer a novel approach to treatment of inflammatory 29 disorders in humans and companion animals. Cats spontaneously develop a wide variety of 30 inflammatory disorders and may potentially benefit from MSC-based therapies. Multiple 31 genes are involved in immunomodulation by MSC and interspecies differences between 32 expressions of these genes exist. The goals of the study were to characterize the expression of 33 genes known to be involved in MSC-based immunomodulation and determine the effect of 34 MSC on proliferation of T-cells in co-culture experiments with PBMC. Unstimulated MSC 35 expressed all immunomodulatory genes studied except for IL-10. Levels of iNOS and FASL 36 were low or undetectable at the RNA level. INFγ stimulation resulted in significant dose 37 dependent upregulation of IDO1, PD-L1, IL-6, COX2 and HGF. Levels of kynurenine were 38 increased after three-day incubation with INFγ. TNFα stimulation increased expression of IL-39 6 at both RNA and protein level as well as upregulated COX2 gene expression and 40 PTGES1.Stimulation with both INFγ and TNFα resulted in significant increase in PGE2 41 levels in cell culture medium. MSC significantly decreased proliferation of ConA stimulated 42 PBMC in co-culture experiments at 1:5 ratio. Our results suggest that feline MSC have 43 similar immunomodulatory gene expression and react to inflammatory cytokines in a manner 44 similar to human MSC. Thus, MSC may play an important role in treatment of feline disease 45 as well as serve as an important translational species to evaluate MSC-based therapies of 46 diseases common to both humans and cats. 47
48
Introduction 49 Mesenchymal stem cells (MSC) have been intensively studied since their first 50 characterization in 1970s [1] . The more recent discovery that MSC are capable of modulating 51 a wide array of immune cells including T-cells, natural killer (NK) cells, dendritic cells, 52 macrophages, B-cells, mast cells and neutrophils [2] [3] [4] [5] [6] [7] [8] [9] of and induction of T-regulatory and 53 B-regulatory cells [10, 11] has led to interest in their use in patients with inflammatory 54 disorders. MSC-based therapy has been successfully implemented in the settings of both 55 induced inflammatory disorders in rodents, [12, 13] as well as spontaneously occurring 56 disorders [11, 14, 15] . Many questions still remain unanswered such as the optimal route of 57 injection, the dose to be used and diseases that can be targeted. Use of large animal models 58 such as cats may assist in the preclinical phase of investigations for humans. Cats 59 spontaneously develop a variety of inflammatory disorders such as asthma [14] , chronic 60 idiopathic (interstitial) cystitis [16] , chronic pancreatitis [17] , chronic kidney disease [18] or 61 inflammatory bowel disease [19] , which can serve as potential translational models for cell 62 based therapies. Many inflammatory mediators have been implicated in immunomodulatory 63
properties of MSC. These factors include idoleamine 2,3 dioxigenase (IDO), inducible nitric 64 oxide synthase (iNOS), prostaglandin E2 (PGE2), interleukin 10 (IL10), hepatocyte growth 65 factor (HGF), transforming growth factor beta (TGFβ), interleukin 6 (IL6), programmed 66 death ligand 1 (PD-L1), Fas ligand (FASL), heme-oxygenase 1 (HMOX1) [3,4,8,13,15,20-67 23] . Interspecies differences exist in immunomodulation between human MSC and murine 68 MSC [20, 21, 24] . In mice, the immunomodulation is considered to be iNOS dependent [25] , 69 while in humans it is IDO1 dependent and iNOS is expressed at very low levels [20, 24] . 70 Information on expression of immunomodulatory genes in cats is lacking. Therefore, the 71 current study was undertaken to characterize the immunomodulatory properties of feline 72
MSC. 73

Materials and Methods
74
Isolation of feline MSC 75 MSC were isolated from adipose tissue of adult cats [20.7 (±5.7) months] as previously 76 described by our group MSC [26, 27] . Tissues were collected from clinically healthy research 77 colony based animals under approved procedures of the Institutional Animal Care and Use 78
Committee at Michigan State University (AUF#: 09/12-171-00). In brief, adipose tissue (2-4 79 grams) was sterilely excised from subcutaneous tissues, minced and incubated in Collagenase 80 of using a plate, a 15 ml spinning tube was utilized to form micromass of 10 6 number of 104 cells/tube. Cells were incubated in differentiation media for at least two weeks before 105 staining for adipogenesis, utilizing Oil-o-red stain. Two-week incubation period was also 106 used for characterization of chondrogenesis and subsequent Alcian Blue staining. Cells in the 107 osteogenesis group were incubated for 3 weeks and stained with Alizarin red stain. 108
Expression of cell surface markers CD90, CD44, CD105, MHCII was analyzed with flow 109 cytometry using previously described [28, 29] Tokyo, Japan) and PGE 2 -d 9 (Cayman Chemical, Ann Arbor, MI) as the internal standard was 167 added. After vortexing for 1 min, the mixture was centrifuged at 10,000 × g for 10 min at 4˚C. 168
One hundred µL supernatant was transferred to an amber autosampler vial with 250-µL glass 169 insert in preparation for LC-MS/MS analysis. Liquid chromatography separations were 170 performed using an Ascentis Express C18 column (10 cm×2.1 mm; 2.7 µm particles, Sigma-171 Aldrich, St. Louis, MO) maintained at 50 ˚C on a Waters ACQUITY UPLC system (Waters, 172 Milford, MA). The autosampler was cooled to 10 ˚C, and injection volume was set to 5 µL. 173
Mobile phase A was 0.1% formic acid in water and mobile phase B was acetonitrile. The 174 flow rate of the LC gradient was 0.3 mL/min. The mobile phase gradient began at 1% B, 175 followed by a linear increase to 40% B at 2 min; then to 80% B at 8 min, and 99% B at 9 min, 176 at which the composition was held until 13 min; then returned to 1% B until 15 min. added to each calibration solution with the same amount as added in cell culture medium. For 188 quantification, the ratio of PGE 2 peak area to its internal standard peak area was plotted 189 against the concentration, fitted by a weighted (1/ Figure 3A ). Interestingly levels of PTGES1 decreased significantly after stimulation 251 with 50 ng of INFγ (-0.45 Log2-fold difference, p<0.05, Figure 3A) . 252
Results
231
Isolation and characterization of MSC
Stimulation of MSC with as low as 0.25 ng/ml of TNFα resulted in significantly 253 increased expression of IL6 ( Figure 3B , 2.7 to 5.2 Log2-fold difference, p<0.001). 254
Expression of COX2 and PTGES1 significantly increased at doses 2.5 and 10 ng/mL of 255 TNFα (COX2: 2.08 Log2-fold increase, p<0.01 and 2.014 Log2-fold increase, p<0.05 256 respectively; PTGES1: 0.758 Log2-fold increase, p<0.05 and 0.8 Log2-fold increase, p<0.01 257 respectively; Figure 3B ). 258
In order to determine if uPA levels were responsible for decrease of levels of HGF in 259 our protein assay, we investigated uPA levels after stimulation with a single dose of INFγ. 260 This stimulation resulted in significant upregulation of uPA at gene expression level (2.47 261
Log2-fold increase, p<0.05, Figure 3A) . 262
All other genes tested remained unaltered by stimulation with inflammatory cytokines. 263
In summary, we have identified that 24-hour stimulation INFγ results in significant 264 dose dependent upregulation of IDO1, IL6, PD-L1, COX2 and uPA, while decreased 265 PTGES1. TNFα stimulation resulted in upregulation of COX2 and PTGES1. 266 Protein and metabolite quantification 267 Levels of IL6 increased after stimulation with each cytokine over 72 hours (TNFα, 268 p<0.01; INFγ, p<0.05; both, p<0.001; Figure 4A ). Levels of IL6 were also affected by 269 inflammatory environment after 24-hour cytokine stimulation (Supplemental Figure 3) . 270
After 72 hours of stimulation with TNFα amount of TGFβ1 significantly increased 271 (p<0.05; Figure 4B ), while stimulation with both INFγ and TNFα decreased the concentration 272 of secreted TGFβ1 as compared to unstimulated cells (p<0.01; Figure 4B ). 273
Interestingly, there were no differences in the concentration of HGF between different 274 conditions at 72 hours, but levels of HGF decreased significantly after three days of 275 incubation compared to day 1 (Supplemental Figure 1) , and where on the lower end of 276 detection of the assay. 277
Levels of PGE2 significantly increased after stimulation of cell with both INFγ and 278
TNFα for three days (p<0.05, Figure 5A ). 279 IL10 values were below the detection limit of the only commercially available assay 280 for feline IL10. 281
IDO activity 282
INFγ stimulation significantly increased kynurenine levels in cell culture supernatants 283 after 3 days of incubation compared to unstimulated cells (p<0.001, Figure 5B) . 284
Co-culture experiments 285
Co-culture of irradiated MSC with ConA stimulated PBMCs at 1:5 ratio significantly 286 blocked the proliferation of PBMCs as measured by EdU incorporation assay (p<0.001; 287 human MSC [20, 34] , whereas in the mouse, this gene is not responsive to INFγ [3, 21, 24, 35] . 298
Mouse MSC induce iNOS upon stimulation with INFγ, one of the key molecules involved in 299 murine immunomodulation [25, 36] . Expression of iNOS by feline MSC in our experimental 300 conditions was low or undetectable, which closely parallel human MSC [24] . 301
Expression of IL6 was upregulated by both INFγ and TNF stimulation at the RNA 302 level and that was further confirmed by protein assays. Constitutive expression of IL6 is 303 characteristic for MSC [37, 38] . 304 FASL and IL10 transcripts were undetectable in the feline MSC and stimulation using 305
INFγ and TNFα did not change this. FASL expression has been recently put forth as being 306 important for MSC mediated T-cell apoptosis [15] . Interestingly the authors of that study did 307 not detect expression of PD-L1 in MSC. However, we have observed strong induction of PD-308 L1 after stimulation with INFγ. Our findings are concordant with data reported from placenta 309 derived MSC [39, 40] , where expression of PD-L1, but not FASL, has been reported Thus, 310
MSC may use different effectors to induce apoptosis of T-cells. The differences may arise 311 from culture conditions, source of MSC (adipose, placenta, bone-marrow). In previously 312 described studies, bone marrow derived [15, 40] and placenta derived cells were utilized [22] . 313
Expression of IL10 by feline MSC was not detectible in our study both at the gene and 314 protein expression level. At the protein level, the signals generated were below the limit of 315 detection of the commercially available feline IL10 assay (<125 pg/ml,). Reports on the 316 production of IL10 by MSC are not concordant. In some studies with human MSC, IL10 was 317 detectable at the gene expression level [41] and at the protein level [22, 35] , while in others, 318 no IL10 was detected [3, 42] . Both the source of MSC and culture conditions may affect the 319 production of IL10. 320
We have also identified that feline MSC upregulated COX2 in response to both INFγ 321 and TNFα stimulation, although all of the PGE2 synthases were strongly expressed in our 322 data set we identified significant increase in PTGES1 expression only after TNFα stimulation, 323
while stimulation with INFγ resulted in significant decrease in expression at the highest dose 324
given. The results on PTGES1 have to be treated with caution as the changes, although 325 statistically significant, may not be biologically effective due to low level of changes. We 326 also identified significant increase in PGE2 levels in cell culture medium after stimulation of 327 MSC with both INFγ and TNFα, while this effect was not identified after stimulation with 328 only a single cytokine. One potential hypothesis would be that increased degradation of 329 PGE2 through upregulation of enzyme responsible for PGE2 degradation HPGD 330 (Hydroxyprostaglandin Dehydrogenase 15-(NAD)). We have investigated this possibility and 331 no increase in expression of HPGD was identified after stimulation with cytokines studied 332 (data not shown). Thus we hypothesize that strong expression of PGE2 syntheses in our 333 experimental setting have precluded additional induction through stimulation. Another 334 explanation could be potential species-specific differences in prostaglandin metabolism and 335 further work would need to be done in order to answer this question. 336
Release of HGF by feline MSC into the supernatant was significantly decreased in all 337
of the conditions the amount of HGF further decreased at 72 hours. In a study with human 338 MSC, 24 hr stimulation with INFγ was reported to increase HGF release by 10 times [43] , 339 however, the INF γ concentration used was four times higher (200ng/ml) as compared to our 340 study. Thus, different doses of INFγ may induce release of HGF at different time points. 341 HGF is being released as an inactive precursor, and in order for it to be fully functional, it 342 requires proteolytic cleavage through urokinase type plasminogen activator (uPA) [44] . In 343 order to investigate if this enzyme is being induced by INFγ we performed QPCR analysis of 344 uPA after cytokine stimulation. We found significant 2-Log2-fold induction of uPA after 345 stimulation of MSC with INFγ dose used in ELISA studies (50ng/mL,). One could speculate 346 that this allows for HGF to be bound by its receptor MET. Interestingly we found that after 3 347 days of incubation the levels of HGF were hardly detectable in all of the conditions measured, 348 which may suggest that HGF is maybe being cleaved by uPA in all of the conditions. 349
The levels of TGFβ1 were significantly higher after stimulation with TNFα for 3 days, results have been previously reported in this aspect [25, 43, 46] . The MSC mediated blockade 360 of ConA PBMC proliferation was previously described [47] and our results are similar to 361 these previously presented. 362
Significant reduction of stimulated PBMCs seen in co-culture studies described above, 363 along with the gene expression of immunomodulatory molecules documented, provides a 364 strong rationale for clinical utilization of MSCs in treatment of feline inflammatory disease as 365 well as for the utilization of cats in translational studies. 366
The current study documents that feline MSC share many similarities in 367 immunomodulatory properties as human MSC and adds to the limited information available 368 from large animal systems. Spontaneously occurring chronic inflammatory disorders in cats 369 and dogs may serve as translational models of MSC-based therapy of human diseases [48] . 370
Studies of MSC in mice have previously reported differences in mice as compared to humans 371 especially with regard to expression of INOS vs IDO [21, 24] . The appropriateness of mice 372 models for human immune disorders has recently been challenged [49] [50] [51] . Although mouse 373 models will remain important tools in the biomedical field [52], use of spontaneously 374 occurring disorders in cats can potentially successfully fill in the gap between mouse and 375 human in development of new treatment strategies for a variety of disorders [48, 53] . 376
The immunomodulatory properties of feline adipose derived MSC documented in 377 this study, provide the rational for the utilization of MSC based approaches to feline diseases 378 with inflammatory components for the treatment of both the feline diseases as well as an 379 
